Biogen Statistics

Total Valuation

Biogen has a market cap or net worth of GBP 13.29 billion. The enterprise value is 16.55 billion.

Market Cap	13.29B
Enterprise Value	16.55B

Important Dates

The last earnings date was Thursday, May 1, 2025.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.21%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	146.00M

Valuation Ratios

The trailing PE ratio is 11.61.

PE Ratio	11.61
Forward PE	n/a
PS Ratio	1.75
PB Ratio	1.01
P/TBV Ratio	18.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	14.45
EV / Sales	2.25
EV / EBITDA	6.92
EV / EBIT	9.31
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.39.

Current Ratio	1.44
Quick Ratio	0.87
Debt / Equity	0.39
Debt / EBITDA	2.08
Debt / FCF	n/a
Interest Coverage	9.47

Financial Efficiency

Return on equity (ROE) is 9.19% and return on invested capital (ROIC) is 6.47%.

Return on Equity (ROE)	9.19%
Return on Assets (ROA)	5.43%
Return on Invested Capital (ROIC)	6.47%
Return on Capital Employed (ROCE)	10.43%
Revenue Per Employee	999,053
Profits Per Employee	150,554
Employee Count	7,605
Asset Turnover	0.36
Inventory Turnover	1.00

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.22% in the last 52 weeks. The beta is 0.06, so Biogen's price volatility has been lower than the market average.

Beta (5Y)	0.06
52-Week Price Change	-44.22%
50-Day Moving Average	132.84
200-Day Moving Average	166.22
Relative Strength Index (RSI)	43.78
Average Volume (20 Days)	2,607

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biogen had revenue of GBP 7.60 billion and earned 1.14 billion in profits. Earnings per share was 7.83.

Revenue	7.60B
Gross Profit	5.74B
Operating Income	1.83B
Pretax Income	1.36B
Net Income	1.14B
EBITDA	2.37B
EBIT	1.83B
Earnings Per Share (EPS)	7.83

Full Income Statement

Balance Sheet

The company has 2.01 billion in cash and 5.12 billion in debt, giving a net cash position of -3.11 billion.

Cash & Cash Equivalents	2.01B
Total Debt	5.12B
Net Cash	-3.11B
Net Cash Per Share	n/a
Equity (Book Value)	13.14B
Book Value Per Share	89.95
Working Capital	1.80B

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.58%, with operating and profit margins of 24.15% and 15.07%.

Gross Margin	75.58%
Operating Margin	24.15%
Pretax Margin	17.85%
Profit Margin	15.07%
EBITDA Margin	31.22%
EBIT Margin	24.15%
FCF Margin	n/a

Dividends & Yields

Biogen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.21%
Shareholder Yield	-0.21%
Earnings Yield	8.61%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a